Vedolizumab

Brand name: Entyvio

DILI Likelihood

Score D — Possible Hepatotoxin

Single case reports have appeared implicating this drug, but the evidence is limited.

Fewer than 3 cases have been reported in the literature. No characteristic signature has been identified, and the case reports may not have been very convincing.

Scoring guide (A through X) →

Classification

Primary class Gastrointestinal

Secondary class Inflammatory bowel disease

FDA approval 2014

Full LiverTox article Search another medication